Published 11/03/2009 by RTTNews.com
InterMune, Pharmasset Say Robust Antiviral Suppression Achieved With Combination Of RG7128 And RG7227 - Update
11/3/2009 4:04 PM ET RELATED NEWS TOP MARKET NEWS (RTTNews) - Tuesday, biotechnology company InterMune, Inc. (ITMN: News ) and antiviral drug developer Pharmasset, Inc. (VRUS) announced results from all patient cohorts of the INFORM-1 trial, an innovative Phase 1...
Share this
What others report on the same story